Skip to main content
Log in

Disease Management and the Role of Pharmacists

  • Primer
  • Published:
Disease Management and Health Outcomes

Summary

Disease management is a new method of managing healthcare which has arisen in response to rising healthcare costs and the integration of healthcare providers. Disease management is defined as an integrated, systems approach to healthcare designed to influence the progression of disease within selected patient populations. In disease management, a detailed analysis of a patient population’s medical needs and the resources it consumes is performed in order to design, implement and control the delivery of care. Selection of disease management strategies is based on application of the best scientific evidence currently available Ideally, disease management crosses organisational and professional boundaries resulting in seamless care for patients.

Originating in the managed care literature, disease management has five primary characteristics. The first is a disease focus in which interventions target patient populations which are at risk of or have defined diseases. The second characteristic is the use of a population-based strategy, i.e. one that emphasises the overall care of patient populations rather than of individual patients. The third characteristic of disease management is a systems approach in which the various components of the healthcare system are integrated into a seamless process of care. Fourth, disease management is evidence-based in that it uses information from the medical literature and clinical experience to develop clinical guidelines and protocols for application to clinical practice. Finally, disease management focuses on outcomes rather than processes of care.

Pharmacists can fulfil numerous roles in disease management because effective drug therapy is the key to managing most diseases. Pharmacist participation in disease management is often directed toward meeting the needs of managed care organisations (MCOs). Pharmacists will be better able to meet the needs of MCOs if the services they provide are consistent with a population-based, integrated systems approach to healthcare. Pharmacists can accomplish this by working with other pharmacists to provide disease management services for large managed care populations over wide geographical areas and by integrating their services with other healthcare providers. Pharmacists can provide disease management outside of a managed care model by individually submitting claims for disease management services to insurers, by having patients pay for services out-of-pocket and by using disease management as a way of differentiating themselves from competitors. Obstacles to pharmacist participation in disease management include the continued short term, component focus of healthcare insurers, the need for more detailed patient information and outcomes data for pharmacists and the need for more training in disease management for pharmacists.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Lumsdon K. Disease state management: the heat and headaches over retooling patient care create hard labor. Hosp Health Netw 1995; 69 (7): 34–42.

    PubMed  CAS  Google Scholar 

  2. Muirhead G. Is it here? Disease management: a reality check. Drug Topics 1995 Apr 10; 139 (7): 28, 33.

    Google Scholar 

  3. Castignoli WG. Is disease management good for an ailing industry? Med Marketing Media 1995; 1: 46–53.

    Google Scholar 

  4. Hunter DJ, Gillian F. Disease management. BMJ 1997; 314 (7099): 50–3.

    Article  Google Scholar 

  5. Peterson C. Disease state management: a new view of an old idea. Manage Healthcare 1995; 5: 45–52.

    Google Scholar 

  6. Piocher DW. Disease management. In: Kongstvedt PR, editor. The managed healthcare handbook. 3rd ed. Gaithersburg (MD): Aspen, 1996; 318–29.

    Google Scholar 

  7. Southwick K. Disease management update. Manage Healthcare 1995 May; 5 Suppl. 1: S31–4.

    Google Scholar 

  8. Levitt KR, Lazenby HC, Braden BR, et al. National health expenditures. Health Care Financ Rev 1996; 18 (1): 1–43.

    Google Scholar 

  9. Bodenheimer TS, Grumbach K. Understanding health policy: a clinical approach. 1st ed. Stamford (CT): Appleton & Lange, 1995.

    Google Scholar 

  10. Leape LL. Error in medicine. JAMA 1994; 272 (23): 1851–7.

    Article  PubMed  CAS  Google Scholar 

  11. Winslow R. Quality of HMOs in the US varies widely, report finds. Wall Street J (Interactive) 1997 Oct 2.

  12. Anonymous. The changing health care system: fostering relationships between managed care and pharmacy. Washington, DC: American Pharmaceutical Association & Academy of Managed Care Pharmacy, 1996.

  13. McGahan AM. Industry structure and competitive advantage. Harvard Business Rev 1994 Nov-Dec; 72: 115–24.

    Google Scholar 

  14. Navarro RP, editor. Ciba Geneva Pharmacy Benefit Report. Summit (NJ): CibaGeigy, 1996.

    Google Scholar 

  15. Holdford DA, Kennedy DT, Bernadella P, et al. Implementing disease management in community pharmacy practice. Clin Ther 1998; 20 (2): 328–39.

    Article  PubMed  CAS  Google Scholar 

  16. Holdford DA. Barriers to disease management. Am J Health Syst Pharm 1996; 53: 2093–6.

    PubMed  CAS  Google Scholar 

  17. Sclar DA. Disease management: an overview for the managed care pharmacist. Drug Benefit Trends 1996; 7 (5): 8, 10–11, 15–16.

    Google Scholar 

  18. Taplin S, Galvin MS, Payne T, et al. Putting population-based care into practice: real option or rhetoric? J Am Board Fam Pract 1998; 11 (2): 116–26.

    PubMed  CAS  Google Scholar 

  19. Shortell SM, Kaluzny AD. Health care management organization design and behavior. 3rd ed. Albany (NY): Delmar Publishers Inc, 1994.

    Google Scholar 

  20. Ken T. Disease state management: continuous health-care improvement. Bus Health 1995; 13 (4): 64–9.

    Google Scholar 

  21. Stern CS. How to evaluate disease state management programs. J Managed Care Pharm 1997; 3: 270, 273–274, 277–78.

    Google Scholar 

  22. Amerson AB. Population-based pharmaceutical care. J Am Pharm Assoc 1998; 38 (1): 7.

    Google Scholar 

  23. Soumerai SB, McLaughlin TJ, Ross-Degnan D, et al. Effects of limiting Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia. N Engl J Med 1994; 331: 650–5.

    Article  PubMed  CAS  Google Scholar 

  24. Ellrodt G, Cook DJ, Lee L, et al. Evidence-based disease management. JAMA 1997; 278 (20): 1687–93.

    Article  PubMed  CAS  Google Scholar 

  25. Wongwiwatthananukit S, Jack HS, Popovich N. Smoking cessation: part 1 — an overview. J Am Pharm Assoc 1998; 38 (1): 58–70.

    Google Scholar 

  26. Woolf SM. Practice guidelines: a new reality in medicine. I: recent developments. Arch Intern Med 1990; 150: 1811–8.

    Article  PubMed  CAS  Google Scholar 

  27. Holdford DA, Smith S. Improving the quality of outcomes research involving pharmaceutical services. Am J Health Syst Pharm 1997; 54: 1434–42.

    PubMed  CAS  Google Scholar 

  28. Munroe WP, Dalmady-Israel C. The community pharmacist’s role in disease management. Drug Benefit Trends 1997; 9 (9): 74–7.

    Google Scholar 

  29. Gannon K. State of disease management. Drug Topics 1997; 141 (1): 42.

    Google Scholar 

  30. Rodgers K. Saving lives, saving dollars; Ohio institutes disease state management for heart failure. Drug Topics 1996; 140 (13): 90.

    Google Scholar 

  31. Lima HA. Disease management in the alternate-site health care setting. Am J Health Syst Pharm 1998 Mar 1; 55: 471–6.

    PubMed  CAS  Google Scholar 

  32. Trice SB. DUE: moving toward disease management. Consult Pharm 1995; 10 (5): 402, 406–408, 410, 420.

    Google Scholar 

  33. Marcille JA. Contracting: how will you measure up? Managed Care Pharm Pract 1995 May/Jun; 2 (3): 16–23.

    Google Scholar 

  34. Munroe WP, Kunz K, Dalmady-Israel C, et al. Economic evaluation of pharmacist involvement in disease management in a community pharmacy setting. Clin Ther 1997; 19 (1): 113–23.

    Article  PubMed  CAS  Google Scholar 

  35. Johnson JA, Bootman JL. Drug-related morbidity and mortality: a cost-of-illness model. Arch Intern Med 1995; 155: 1949–56.

    Article  PubMed  CAS  Google Scholar 

  36. Hatoum HT, Akhras K. 1993 Bibliography: a 32-year literature review on the value and acceptance of ambulatory care provided by pharmacists. Ann Pharmacother 1993; 27 (9): 1106–19.

    PubMed  CAS  Google Scholar 

  37. Johnson JA, Bootman JL. Drug-related morbidity and mortality and the economic impact of pharmaceutical care. Am J Health Syst Pharm 1997; 54: 554–8.

    PubMed  CAS  Google Scholar 

  38. Curtiss FR. Lessons learned from projects in disease management in ambulatory care. Am J Health Syst Pharm 1997; 54: 2217–29.

    PubMed  CAS  Google Scholar 

  39. Currie JD, Chrischeilles EA, Kuehl AK, et al. Effect of a training program on community pharmacists’ detection of and intervention in drug-related problems. J Am Pharm Assoc 1997; NS37 (2): 182–91.

    CAS  Google Scholar 

  40. Navarro RP, editor. Novartis Pharmacy Benefit Report (after report: 1997 Facts and Figures). East Hanover (NJ): Novartis, 1997.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to David Holdford Ph.D..

Additional information

About the Author: David A. Holdford, Ph.D., is Assistant Professor of Pharmacy Administration, College of Pharmacy, Virginia Commonwealth University (VCU), Richmond. At VCU, Dr Holdford teaches management, services marketing and pharmacoeconomics. Dr Holdford’s current research interests focus on methods for assessing the quality of pharmaceutical services and the marketing of innovative pharmaceutical programmes. He has published research on disease management, outcomes research and reimbursement of pharmacists for cognitive services.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Holdford, D. Disease Management and the Role of Pharmacists. Dis-Manage-Health-Outcomes 3, 257–270 (1998). https://doi.org/10.2165/00115677-199803060-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00115677-199803060-00001

Keywords

Navigation